feed,title,long_url,short_url
Benzinga,Cabaletta Bio's Cell Therapy In Skin Blistering Disorder Shows Favorable Safety Profile,https://benzinga.com/general/biotech/21/05/20916930/cabaletta-bios-cell-therapy-in-skin-blistering-disorder-shows-favorable-safety-profile,https://j.mp/33c0LNy
Benzinga,Cocrystal Pharma Stock Gains After Laying Out Plans To Launch Another COVID-19 Antiviral Candidate,https://benzinga.com/general/biotech/21/05/20915718/cocrystal-pharma-stock-gains-after-laying-out-plans-to-launch-another-covid-19-antiviral-candidat,https://j.mp/3uhEERx
